Hyundai Pharmaceutical

004310 · KOSPI · ₩004310 · 현대약품

₩6,850▲ ₩150 (2.24%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me

Income statement

20252024202320222021
Revenue₩192B₩176B₩181B₩163B₩140B
Cost of sales₩112B₩102B₩104B₩94B₩83B
Gross profit₩80B₩73B₩77B₩69B₩56B
Operating income₩4.2B₩181M₩6.9B₩8B−₩1.6B
Net income₩2.5B−₩575M₩6.1B−₩165M−₩3.2B
Net income to shareholders₩2.5B−₩575M₩6.1B−₩165M−₩3.2B

Balance sheet

20252024202320222021
Total assets₩163B₩156B₩155B₩181B₩164B
Current assets₩81B₩80B₩85B₩102B₩85B
Cash and equivalents₩2.5B₩10B₩16B₩30B₩22B
Total liabilities₩81B₩77B₩70B₩95B₩77B
Current liabilities₩71B₩59B₩65B₩81B₩46B
Borrowings₩50B₩48B₩38B₩39B₩29B
Total equity₩82B₩79B₩85B₩87B₩87B
Shareholders' equity₩82B₩79B₩85B₩87B₩87B

Cash flow

20252024202320222021
Cash from operations−₩123M−₩2.4B−₩4.5B₩12B₩5.1B
Capital spending₩4.6B₩9.8B₩4.6B₩2.4B₩1.3B
Free cash flow−₩4.7B−₩12B−₩9.1B₩9.2B₩3.8B
Dividends paid₩784M−₩923M₩826M₩836M₩1.2B

Consolidated where available. Amounts in won.

Also known as: Hyundai Pharmaceutical / 현대약품 / 004310 / KRX:004310

Source: KRX statistical information